Amneal Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary

Amneal Pharmaceuticals

03/05/2024 15:23

* Amneal Pharmaceuticals Inc  AMRX.OQ  reported quarterly
adjusted
earnings of 14 cents​​ per share for the quarter ended in March,
higher than the same quarter last year, when the company
reported EPS of 12 cents.  The mean expectation of five analysts
for the quarter was for earnings of 9 cents per share. Wall
Street expected results to range from 8 cents to 11 cents per
share.
    * Revenue rose 18.2% to $659.19 million from a year ago;
analysts
expected $619.03 million. 
    * Amneal Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 30 cents​.
    * The company reported a quarterly loss of $91.64 million.
    * Amneal Pharmaceuticals Inc shares had risen by 2.5% this
quarter and gained 2.3% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 19.8%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and 1 "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for Amneal
Pharmaceuticals Inc is $7.50 
This summary was machine generated from LSEG data May 3 at 02:23
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      0.09           0.14           Beat
 Dec. 31 2023      0.09           0.14           Beat
 Sep. 30 2023      0.13           0.19           Beat
 Jun. 30 2023      0.11           0.19           Beat